Difference between revisions of "DZI20-210-Case-1"
From MGH Learn Pathology
(Created page with "{{dziCase |order_date=October 21, 2020 02:16:00 PM |user=Vn048 |dziorder=DZI20-210 |case_id=1 |publish_timestamp=Choose_date 13:00 |clinical_hx=70 yo with 3 week history of he...") |
|||
Line 6: | Line 6: | ||
|publish_timestamp=Choose_date 13:00 | |publish_timestamp=Choose_date 13:00 | ||
|clinical_hx=70 yo with 3 week history of hemorrhagic tumors | |clinical_hx=70 yo with 3 week history of hemorrhagic tumors | ||
− | |case_diagnosis=CD8+ cutaneous T cell lymphoma. | + | |case_diagnosis=SKIN: LEFT upper back and arm: CD8+ cutaneous T cell lymphoma. |
IHC: Aypical lymphocytes are CD3+ CD7+ CD5+ (subset), CD8+, TIA+, Perforin+, Granzyme+, and negative for CD2, CD56, CD4, CD30. CD25 shows weak reactivity in ~40-50% of cells. Mib1 is approximately 90%. | IHC: Aypical lymphocytes are CD3+ CD7+ CD5+ (subset), CD8+, TIA+, Perforin+, Granzyme+, and negative for CD2, CD56, CD4, CD30. CD25 shows weak reactivity in ~40-50% of cells. Mib1 is approximately 90%. | ||
Line 13: | Line 13: | ||
|order_date=October 21, 2020 02:16:00 PM | |order_date=October 21, 2020 02:16:00 PM | ||
|user=Vn048 | |user=Vn048 | ||
− | |source_filename= | + | |source_filename=Z0FBQUFBQmZrRVV6NGxsTGZmc1FyOUpBRzhIbkNIdHZDbVhwN1ZWQnNFMnE4ZmFWTHQ0TDliLXZsU0Q0U2hyWjA4LWl2RTJSN1NhZnFaSWZpaF9VT09rWGtIamlYVW85aWc9PQ |
|slide_stain=H&E | |slide_stain=H&E | ||
|slide_anatomy=Show | |slide_anatomy=Show | ||
}} | }} |
Revision as of 09:27, October 21, 2020
No results
No resultsNo results
No resultsNo results